comparemela.com
  1. Home
  2. Live Updates
  3. Darren Feldman - Breaking News

Latest Breaking News On - Darren feldman - Page 1 : comparemela.com

Debiopharm reveals phase 1/2 GaLuCi research results

The multi-centre international clinical trial will evaluate company’s Debio 0328 candidate - News - PharmaTimes

Ben tranAngela zubelDarren feldmanMemorial sloan kettering cancer centerPeter maccallum cancer centreAustralia based peter maccallum cancerClinical trial

ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances

Complete data from global Phase III ZIRCON study of Telix’s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma.

United statesSan franciscoCharlotte telixKyahn williamsonColin haywardChristian behrenbruchTelix pharmaceuticalsOliver sartor tulane cancer centerAmerican society of clinical oncologyElshad hasanov md anderson cancer centerDrug administrationAndrei iagaru stanford universityAustralian securities exchangeAustralian therapeutic goods administrationDarren feldman memorial sloan kettering cancer centerCorporate communications

Telix Pharmaceuticals Limited: ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances

Complete data from global Phase III ZIRCON study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be presented at American Society of Clinical

United statesUnited kingdomSan franciscoCharlotte telixKyahn williamsonColin haywardChristian behrenbruchTelix pharmaceuticalsOliver sartor tulane cancer centerAmerican society of clinical oncologyElshad hasanov md anderson cancer centerDrug administrationAndrei iagaru stanford universityAustralian securities exchangePrnewswire telix pharmaceuticals limitedAustralian therapeutic goods administration

ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances

Complete data from global Phase III ZIRCON study of Telix s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be.

United statesUnited kingdomSan franciscoCharlotte telixKyahn williamsonColin haywardChristian behrenbruchTelix pharmaceuticalsOliver sartor tulane cancer centerAmerican society of clinical oncologyElshad hasanov md anderson cancer centerDrug administrationAndrei iagaru stanford universityAustralian securities exchangePrnewswire telix pharmaceuticals limitedAustralian therapeutic goods administration

ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances

ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan franciscoUrothelial carcinomadateCharlotte telixColin haywardChristian behrenbruchTelix pharmaceuticalsAmerican society of clinical oncologyElshad hasanov md anderson cancer center abstractDrug administrationAustralian securities exchangePrnewswire telix pharmaceuticals limitedAustralian therapeutic goods administrationOliver sartor tulane cancer center abstractHealth abstract
© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.